Attention and Memory in Tramadol Addiction

Document Type : Original Article

Author

Department of Neurology and Psychology, Faculty of Medicine, Sohag University.

Abstract

Background and Objective: Impairment in cognitive domains  occurs commonly in substance use disorders. Tramadol abuse is a common problemin Egypt. The objective of this study was to study the effect of tramadol addiction on attention and memory.
Methods: This study included 30 patients with tramadol addiction and 30 control subjects (matched for age, sex, and education).The participants were interviewed using attention and memory subscales of Montreal Cognitive Assessmenttest (MoCA) and Trail making test A and B.
Results: The average score of memory in the tramadol addiction group was 2.46±1.33, while the average score in the control group was4.47±1.04, there was significant difference between the two groups with P value <0.0001.There was no statistically significant impairment in Trail making tests A and B.Therewas no association between cognitive impairment and sociodemographicor clinical factors.
Conclusions: Tramadol addiction causes impairment in memory.There is no effect of tramadol dose or duration of abuse on cognitive impairment.

1-      Abo-Elmagd, S., Kodera, A., Okasha, T., Gawad, T.,and Rawson, R. (2013). Tramadol use in Egypt: The emergence of a new public health problem. Canadian Journal of Addiction Medicine, 4(1), p5.
2-      Bassiony, M., Youssef, U., Hassan, M. S., Salah El-Deen, G. M., El-Gohari, H., Abdelghani, M., Abdalla, A. & Ibrahim, D. H. (2017). Cognitive impairment and tramadol dependence.Journal of Clinical Psychopharmacology, 37(1),61–66.
3-      McLellan, A., et al. (1992). The fifth edition of the Addiction Severity Index.Journal of substance abuse treatment, 9(3), 199-213.
4-      Mintzer, M. Z., Lanier, R. K., Lofwall, R. M., et al. (2010). Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.Drug Alcohol Depend, 111, 265-268.
5-      Nasreddine, Z. S., Phillips, N. A., Bedirian, V., et al. (2005).The montrealcognitive assessment, MoCA: a brief screening tool for mild cognitiveimpairment. J Am GeriatrSoc, 53, 695– 699.
6-      Ng, K. F., Yuen, T. S., & Ng, V. M. (2006).A comparison of postoperative cognitive function and pain relief with fentanyl or tramadol patient-controlled analgesia.J ClinAnesth, 18, 205–210.
7-      Qassem, T., Beshry, Z., Assad, T., Omara, A., &Abdmawgoud, M. (2003).Profiles of neurophysiological dysfunction in chronic heroin users. M.D degree thesis, faculty of medicine, Ain shams university.
8-      Rahman, T. T. and El Gaafary, M. M., (2009).Montreal Cognitive Assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatrics and Gerontology International, 9(1), 54-61.
9-      Reitan, R. (1958). Validity of the Trail Making Test as an indicator of organic brain damage.Perceptual and Motor Skills, 8, 271-276.
10-  Shadnia, S., Soltaninejad, K., Heydari, K., Sasanian, G., &Abdollahi, M. (2008).Tramadol intoxication: a review of 114 cases .Hum ExpToxicol, 27(3), 201–205.
11-  Sjogren, P., Thomsen, A. B., & Olsen, A. K. (2000).Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy.J Pain Symptom Manage, 19(2), 100–108.
12-  Taghaddosinejad, F., Mehrpour, O., Afshari, R., Seghatoleslami, A., Abdollahi, M. (2011).Factors Related to Seizure in Tramadol Poisoning and Its Blood Concentration J Med Toxicol, 7(3), 183–188.
13-  Ulusoy, H., Coskun, I., &Arslan, M. (2016).Effects of midazolam or tramadol premedication on early cognitive function in endoscopic retrograde cholangiopancreatography (ERCP): A randomized, controlled, double-blind study. Journal of International Medical Research, 44(3), 542–556.
14-  Zacny, J. P. (2005). Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.Drug Alcohol Depend, 80, 273–278.
15-  akaryaee, H., Mollazadeh, J., Aflakseir, A., Khormaei, F., &Soofi, A. (2012).Cognitive Impairment in Methamphetamine, Buprenorphine and Tramadol Users.European Journal of Scientific Research, 68(3), 321-327.